Peroneal longus tendon rupture after fluoroquinolone therapy: A case study

Authors

  • Khurram Khan, DPM Clinical Associate Professor, Temple University School of Podiatric Medicine, Medicine Department, Philadelphia, Pennsylvania, USA
  • Priyal Patel Podiatric Medical Student at Temple University School of Podiatric Medicine, Philadelphia, Pennsylvania, USA
  • Kari Phan, DPM Resident Podiatric Physician, MetroWest Medical Center, Framingham, Massachusetts, USA
  • Ebony Love, DPM Clinical Associate Professor, Temple University School of Podiatric Medicine, Medicine Department, Philadelphia, Pennsylvania, USA

DOI:

https://doi.org/10.55067/jifaf.v1i6.15

Keywords:

fluoroquinolone, ciprofloxacin, tendinopathies, peroneus longus, peroneus longus tear, tendon rupture

Abstract

Fluoroquinolones are a class of antibiotics that are commonly used to treat gram-negative and gram-positive bacterial infections. Tendinopathies, most commonly affecting the Achilles tendon, are a possible side effect with the use of Fluoroquinolones. Tendinopathies may occur from two hours to six months upon starting a course of fluoroquinolones. This case study presents a patient who had a magnetic resonance imaging (MRI) confirmed peroneus longus tendon rupture with the presence of an os peroneum fracture after two courses of ciprofloxacin treatment, one course five months prior to the injury and the second course one month prior to the injury. Physicians and patients should monitor for tendon soreness and pain in the peroneus longus tendon in addition to the classically documented Achilles tendon following the use of fluoroquinolones.  

References

Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003 Jun 1;36(11):1404-10. doi: 10.1086/375078. Epub 2003 May 20. PMID: 12766835.

Vanek D, Saxena A, Boggs JM. Fluoroquinolone therapy and Achilles tendon rupture. J Am Podiatr Med Assoc. 2003 Jul-Aug;93(4):333-5. doi: 10.7547/87507315-93-4-333. PMID: 12869605.

Kim GK. The Risk of Fluoroquinolone-induced Tendinopathy and Tendon Rupture: What Does The Clinician Need To Know? J Clin Aesthet Dermatol. 2010 Apr;3(4):49-54. PMID: 20725547; PMCID: PMC2921747.

Kato M, Takada S, Kashida Y, Nomura M. Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats. Toxicol Pathol. 1995 May-Jun;23(3):385-92. doi: 10.1177/019262339502300315. PMID: 7659960.

Seidel J, Clarke T, Mathew B. To cipro or not to cipro: bilateral achilles ruptures with the use of quinolones. J Am Podiatr Med Assoc. 2015 Mar;105(2):185-8. doi: 10.7547/0003-0538-105.2.185. PMID: 25815660.

Selmani E, Gjata V, Gjika E. Current concepts review: peroneal tendon disorders. Foot Ankle Int. 2006 Mar;27(3):221-8. doi: 10.1177/107110070602700314. PMID: 16539908.

Evers J, Wähnert D, Grüneweller N, Raschke MJ, Ochman S. Delayed Surgical Reconstruction of a Peroneal Tendon Rupture in an Accessory Os Peroneum: A Rare Differential Diagnosis in Chronic Ankle Pain. J Am Podiatr Med Assoc. 2016 Nov;106(6):439-444. doi: 10.7547/15-092. PMID: 28033048.

Petersen W, Bobka T, Stein V, Tillmann B. Blood supply of the peroneal tendons: injection and immunohistochemical studies of cadaver tendons. Acta Orthop Scand. 2000 Apr;71(2):168-74. doi: 10.1080/000164700317413148. PMID: 10852323.

Pierfitte C, Royer RJ. Tendon disorders with fluoroquinolones. Therapie. 1996 Jul-Aug;51(4):419-20. PMID: 8953821.

Downloads

Published

2022-06-01

How to Cite

1.
Khan K, Patel P, Phan K, Love E. Peroneal longus tendon rupture after fluoroquinolone therapy: A case study. J Int Foot Ankle [Internet]. 2022 Jun. 1 [cited 2022 Aug. 14];1(6). Available from: https://internationalfootankle.org/journal/index.php/JIFAF/article/view/15

Issue

Section

Articles

Most read articles by the same author(s)